contributed to strong cardiometabolic sales in China and India. The company also mitigated supply constraints for the Beckman Coulter BNP product, contributing to 3% growth in infectious disease. Despite Alere’s success in Asia, ex-U.S
fell 1% on an organic basis due to lower pain management revenue from the toxicology business and lower sales of Beckman Coulter BNP tests in light of supply constraints. As expected, health information solutions revenue fell 7%, probably
due to lower utilization, as well as product returns for the INR business and a second-quarter recall of certain Beckman Coulter Triage BNP Tests. The company captured strong growth in India and Africa, though this was partially offset by weak
business. We think the company’s integration of Beckman Coulter is beginning to pay dividends by enhancing margins while ..... Adding to its life science and diagnostics business, Beckman Coulter acquired Siemens’s Microbiology business for
FRANKFURT, July 17 (Reuters) - German engineering group Siemens agreed to sell its clinical microbiology business to Beckman Coulter , a subsidiary of Danaher Corp, as part of a restructuring plan...
t expect any changes to our fair value estimate. (As a reference point, Danaher acquired diagnostics company Beckman Coulter in 2011 for approximately 2 times sales.) We view the divestiture as slightly strengthening Johnson & Johnson
2011 in the life sciences also stands out as Danaher continues to drive operating improvements from recently acquired Beckman Coulter and AB Sciex. During 2012, Danaher generated $3 billion of free cash flow, a 25% improvement versus the prior
in the prior year, after accounting for charges related to the Beckman Coulter acquisition. Our primary concerns for the portfolio reside in the ..... operations is nearly $3.4 billion, driven by strong performance at Beckman Coulter .
think the firm needs a bit more time to drive synergies from Beckman and Esko Artwork. Additionally, the recently announced acquisition ..... onto core margin, but there is only one more quarter that Beckman will not be in the comparisons, and we think the firm may
versus the prior year. The addition of Beckman Coulter helped lift revenue another 33%. Beckman 's integration is going well by management ..... within the firm. The company also noted that Beckman 's working capital has yet to really feel